How much does the targeted drug Olaparib cost?
Olaparib is used alone or in combination with bevacizumab to help maintain the response of certain types of ovarian cancer (the female reproductive organ where eggs are formed), fallopian tube cancer (the tubes that carry eggs released by the ovaries to the uterus), and peritoneal cancer (the layer of tissue that lines the abdomen) in people who have responded completely or partially to the first or subsequent chemotherapy treatment.
Lynparza is also used to treat certain types of breast cancer that have spread to other parts of the body and have not improved or worsened after treatment with other therapies. It is also used to treat certain types of early breast cancer in people who have already received other chemotherapy. Lynparza is also used to treat a certain type of prostate cancer that has spread to other parts of the body, is no longer responding to drugs or surgical treatment that lowers testosterone levels, and has progressed after treatment with enzalutamide (Xtandi) or abiraterone (Yonsa, Zytiga). Olaparib is also used to treat ovarian cancer that does not improve or worsens after treatment with at least three other therapies. Olaparib is also used to help maintain the response of a certain type of pancreatic cancer that has not spread or progressed after the first dose of chemotherapy.
Lynparza The original drug has been launched in China and has entered the scope of Class B medical insurance, but it is only available to patients who meet the indications. The price of each box of 150mg*56 tablets may be around RMB 6,000. There are price differences for drugs of different specifications. There are also Olaparibgeneric drugs produced overseas. The specifications produced by Bangladesh pharmaceutical factories150mg*120 tablets per box may cost around RMB 4,000 (the price may fluctuate due to the exchange rate). Its drug ingredients are basically the same as those of the Olaparib original drug. For more drug information and specific prices, please consult Yaode Medical Consultant.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)